NCT06206265: Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS)
- State
- Under way
- Phase
- Phase 2
- People
- 14 taking part
- Started
- 17 Jan 2024
- Primary completion
- 1 Mar 2026
- Arms
- Open Label Oral Psilocybin
- Results
- None posted
- 16 Jan 2024: Trial registered
- 17 Jan 2024: Trial started